Catalysts allow a reaction to proceed via a pathway that has a lower activation energy than the uncatalyzed reaction. In homogeneous catalysis, catalysts are in the same phase as the reactants.287193-07-1, C8H12O4. A document type is Patent, introducing its new discovery., Safety of Ethyl 4-oxotetrahydro-2H-pyran-2-carboxylate
Compounds of formula (I’): (I); wherein: R1 represents substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl; X represents-(CRkaRkb)k-; Rka and Rkb are each independently hydrogen or C1-6alkyl; k is 0-5; Y represents-NR3-or a bond; R3 represents hydrogen or C1-6alkyl; Z represents a moiety of formula (ZA), (ZB), (ZC), (ZD), (ZE), or (ZF); A represents-(CRjaRjb)j-; Rja and Rjb are each independently hydrogen or C1-6alkyl; j is 0, 1 or 2, and; R2 represents unsubstituted or substituted aryl; and salts and solvates thereof are CCR3 receptor antagonists and are thus indicated to be useful in therapy.
Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.Safety of Ethyl 4-oxotetrahydro-2H-pyran-2-carboxylate. This is the end of this tutorial post, and I hope it has helped your research about 287193-07-1
Reference：
Tetrahydropyran – Wikipedia,
Tetrahydropyran – an overview | ScienceDirect Topics